Inhibition of mTORC1 may activate the MAPK pathway through a PI3K-dependent feedback loop [45], which explains why BEZ235 was seen here to activate ERK1/2 in thyroid cancer cells. Here, MAPK3 is linked to thyroid gland carcinoma.